Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.

AUTOR(ES)

Reed, M D

RESUMO

The single-dose pharmacokinetics of cefsulodin were evaluated in 12 patients with cystic fibrosis. Each patient received 3 g of cefsulodin intravenously over 30 min. Multiple plasma and urine samples were obtained during the 6-h study period for the determination of cefsulodin. Pharmacokinetic parameters were determined by model-independent methods. Mean values for t1/2, Vss, and CLp were 1.53 h, 0.242 liters/kg, and 117.3 ml/min per 1.73 m2, respectively. Six-hour urine recovery revealed 73.2% of the administered dose with a corresponding cefsulodin urinary clearance of 75.1 ml/min. These pharmacokinetic data in patients with cystic fibrosis appear consistent with data reported for unaffected individuals.

Documentos Relacionados

• Single-dose pharmacokinetics of aztreonam in pediatric patients.
• Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
• Single-dose pharmacokinetics of acyclovir.
• Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
• Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients.